Novel compounds active as muscarinic receptor antagonists

Details for Australian Patent Application No. 2009272303 (hide)

Owner Pfizer Limited

Inventors Lane, Charlotte Alice Louise; Glossop, Paul Alan

Agent Spruson & Ferguson

Pub. Number AU-B-2009272303

PCT Pub. Number WO2010/007552

Priority 61/080,726 15.07.08 US

Filing date 1 July 2009

Wipo publication date 21 January 2010

Acceptance publication date 22 December 2011

International Classifications

C07D 211/46 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2010/007552 Priority application(s): WO2010/007552

22 December 2011 Application Accepted

  Published as AU-B-2009272303

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009272332-Low perfusion signal processing systems and methods

2009272292-A gripping organ for load-moving vehicles